Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trials

被引：0
|
作者：
Caiyun Zheng
Meimei Lin
Yan Chen
Haiting Xu
Lingqun Yan
Hengfen Dai
机构：
[1] Affiliated Fuqing City Hospital of Fujian Medical University,
[2] Fujian Medical University,undefined
[3] Affiliated Fuzhou First Hospital of Fujian Medical University,undefined
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Sodium glucose cotransporter type 2 inhibitors; Cardiovascular disease; Mortality; Meta‐analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease
    Lin, Donna S. -H.
    Lee, Jen-Kuang
    Huang, Kuan-Chih
    Lin, Ting-Tse
    Lo, Hao-Yun
    DIABETOLOGIA, 2024, 67 (11) : 2459 - 2470
  • [42] Cardiovascular outcomes in patients treated with sodium-glucose transport protein 2 inhibitors, a network meta-analysis of randomized trials
    Tornyos, Daniel
    Meuer, Maximilian
    Lukacs, Reka
    El Abdallaoui, Oumaima El Alaoui
    Kupo, Peter
    Faludi, Reka
    Komocsi, Andras
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [43] The effect of sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes mellitus on cardiovascular and renal outcomes: A systematic review and meta-analysis
    Reyes-Farias, Carlos Ignacio
    Reategui-Diaz, Marcelo
    Romani-Romani, Franco
    Prokop, Larry
    PLOS ONE, 2023, 18 (11):
  • [44] Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
    Li, Dandan
    Wu, Tingxi
    Wang, Tiansheng
    Wei, Hongtao
    Wang, Aihua
    Tang, Huilin
    Song, Yiqing
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (05) : 582 - 590
  • [45] Effects of sodium-glucose cotransporter (SGLT) inhibitors in addition to insulin therapy on glucose control and safety outcomes in adults with type 1 diabetes: A meta-analysis of randomized controlled trials
    Lu, Jingli
    Tang, Lijuan
    Meng, Haiyang
    Zhao, Junjie
    Liang, Yan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (07)
  • [46] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Cancer in Patients with Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials
    Tang, Huilin
    Dai, Qi
    Shi, Weilong
    Zhai, Suodi
    Song, Yiqing
    Han, Jiali
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 396 - 397
  • [47] Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes Implications for the Cardiovascular Disease Specialist
    Bethel, M. Angelyn
    McMurray, John J. V.
    CIRCULATION, 2018, 137 (12) : 1218 - 1220
  • [48] Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Lou, Yake
    Yu, Ying
    Duan, Junchao
    Bi, Sining
    Swe, Khaing Nyein Chan
    Xi, Ziwei
    Gao, Yanan
    Zhou, Yujie
    Nie, Xiaomin
    Liu, Wei
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2020, 11
  • [49] Efficacy of Sodium Glucose Cotransporter 2 Inhibitors In Patients With Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials
    Ahmed, Mushood
    Jain, Hritvik
    Javaid, Hira
    Ahsan, Areeba
    Ramphul, Kamleshun
    Ahmad, Adeel
    Shahid, Farhan
    Basit, Jawad
    Ahmed, Raheel
    CIRCULATION, 2024, 150
  • [50] Effects of sodium-glucose cotransporter 2 inhibitors on renal outcomes in patients with type 2 diabetes: a systematic review and meta-analysis
    Bae, J.
    Park, E.
    Kim, S.
    Kim, K.
    An, J.
    Kim, H.
    Kim, J.
    Kim, S.
    Hahn, S.
    Kim, N.
    DIABETOLOGIA, 2018, 61 : S510 - S510
12345